sodium((2S,3S,4S,5R,6S)-6-(2,3-bis(stearoyloxy)propoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methanesulfonate

ID: ALA3219623

Chembl Id: CHEMBL3219623

PubChem CID: 23719635

Max Phase: Preclinical

Molecular Formula: C45H85NaO12S

Molecular Weight: 851.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCCCC(=O)OCC(CO[C@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC.[Na+]

Standard InChI:  InChI=1S/C45H86O12S.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(46)54-35-38(36-55-45-44(50)43(49)42(48)39(57-45)37-58(51,52)53)56-41(47)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h38-39,42-45,48-50H,3-37H2,1-2H3,(H,51,52,53);/q;+1/p-1/t38?,39-,42-,43+,44-,45+;/m1./s1

Standard InChI Key:  ZJZCMDVKJVQZOK-FYHOLELHSA-M

Associated Targets(Human)

VEGFA Tclin Vascular endothelial growth factor A (159 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 851.24Molecular Weight (Monoisotopic): 850.5840AlogP: 9.68#Rotatable Bonds: 40
Polar Surface Area: 186.12Molecular Species: ACIDHBA: 11HBD: 4
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: -1.22CX Basic pKa: CX LogP: 11.72CX LogD: 9.34
Aromatic Rings: Heavy Atoms: 58QED Weighted: 0.03Np Likeness Score: 0.70

References

1. Takakusagi Y, Takakusagi K, Ida N, Takami M, Matsumoto Y, Kusayanagi T, Nakabayashi T, Aoki S, Murata H, Ohta K, Sugawara F, Sakaguchi K.  (2011)  Binding region and interaction properties of sulfoquinovosylacylglycerol (SQAG) with human vascular endothelial growth factor 165 revealed by biosensor-based assays,  (12): [10.1039/C1MD00180A]
2. Govindarajan M..  (2018)  Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.,  143  [PMID:29126728] [10.1016/j.ejmech.2017.10.015]

Source